Skip to main content

Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?

Anagnostou VK, Lowery FJ, Syrigos KN, Cagle PT, Rimm DL

Publication: Arch Pathol Lab Med (2010) • Vol 134 • Page 613-9PMID: 20367312View on PubMed

Purpose

The purpose of this paper was to determine the effects of core size on immunohistochemical (IHC) staining of tissue microarrays analyzed using automated quantitative analysis (AQUA).

Conclusion

Staining of all biomarkers was highly correlated between a single 0.6 mM field, a 1.0 mM spot, and a 1.5 mM spot.

Studies (1)

Purpose

The purpose of this study was to determine the effects of tissue microarray core size on IHC AQUA scores for biomarkers in breast cancer, lung cancer and melanoma specimens. A randomly chosen single field of 0.6 mM was compared to a composite of several fields representing a 1 mM or 1.5 mM spot.

Summary of Findings

Correlations of 0.94 and 0.92 were observed between HER2 and ER AQUA scores for 0.6 mM fields and 1.5 mM spots on a breast cancer tissue microarray. AQUA scores for mammalian target of rapamycin (mTOR)and p70S6K in 0.6 mM fields and 1.5 mM spots of lung cancer had correlations of 0.96 and 0.98, respectively, and AQUA scores for epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3) in lung cancer had correlations of 0.98 and 0.86 for 0.6 mM fields and 1.0 mM spots. When a 0.6 mM field was compared to a 1 mM spot of melanoma, correlations of 0.92 and 0.90 were observed for mTOR and p70S6K. There were no significant differences between AQUA scores of different sections of the same array.

  • Biospecimens

    TissueLung
    TissueBreast
    TissueSkin
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticMelanoma
  • Platforms

    ProteinImmunohistochemistry
    ProteinTissue microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Breast cancer
    Lung cancer
    Melanoma
    Biospecimen Aliquots and ComponentsAliquot size/volume
    0.6 mm field
    1.0 mm spot
    1.5 mm spot
    Immunohistochemistry SpecificTargeted peptide/protein
    EGFR
    ER alpha
    HER-2/neu
    STAT3
    mTOR
    p70S6K